Tech Company Financing Transactions

PIC Therapeutics Funding Round

Advent Life Sciences and private investors participated in a $5 million Seed funding round for PIC Therapeutics. The financing was announced on 4/16/2020.

Transaction Overview

Company Name
Announced On
4/16/2020
Transaction Type
Venture Equity
Amount
$5,000,000
Round
Seed
Investors

Advent Life Sciences (Lead Investor)

private investors (Belinda Termeer)

Proceeds Purpose
The company intends to use the funds to advance its development ettorts.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
75 Kneeland St. 14th Floor
Boston, MA 02111
USA
Phone
Undisclosed
Email Address
Overview
PIC Therapeutics is a biotechnology company focused on fundamentally changing how we treat cancer by developing a new generation of therapeutics based on the modulation of RNA translation.
Profile
PIC Therapeutics LinkedIn Company Profile
Social Media
PIC Therapeutics Company Twitter Account
Company News
PIC Therapeutics News
Facebook
PIC Therapeutics on Facebook
YouTube
PIC Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Sun Altbach
  Sun Altbach LinkedIn Profile  Sun Altbach Twitter Account  Sun Altbach News  Sun Altbach on Facebook
VP - Bus. Development
Chris VanDeusen
  Chris VanDeusen LinkedIn Profile  Chris VanDeusen Twitter Account  Chris VanDeusen News  Chris VanDeusen on Facebook


 

 

Browse more venture capital transactions:

Prev: 4/16/2020: Nifty Games venture capital transaction
Next: 4/16/2020: Onfido venture capital transaction

 

Share this article

 


About Database of VC Transactions

Our team works diligently to document all VC transactions involving tech companies. VC investment data records on this site come from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary